Current diagnostic options in uveitis – a review of the literature

Monika Modrzejewska, Oliwia Zdanowska, Dawid Świstara


Most cases of uveitis in the pediatric population with an identifiable etiology are non-infectious (67.2–93.8%) and occur in the setting of severe systemic disease. Collaboration among physicians of different specialties and a wide range of specialized diagnostic tests are essential in determining the correct diagnosis of the disease entity. Children are at greater risk of developing serious ophthalmic complications that can threaten vision, interfere with normal childhood development, and lead to severe disability. Therefore, it is important to diagnose the disease at an early stage. A reliable diagnosis allows the implementation of appropriate therapy, which can prevent the occurrence of further complications. The authors of this study reviewed the current literature (2018–2023) in PubMed and Google Scholar, outlining the current diagnostic options for uveitis.


uveitis in children; etiology of uveitis; diagnostics of uveitis in children

Full Text:



Maleki A, Anesi SD, Look-Why S, Manhapra A, Foster CS. Pediatric uveitis: A comprehensive review. Surv Ophthalmol 2022;67(2):510-29.

Niwald A, Grałek M, Piasecka K, Lipiec E. Biological Treatment of Chronic Non-infectious Uveitis in the Developmental Age. Acta Ophthalmol Pol 2019;121(3):131-5.

Shin Y, Kang JM, Lee J, Lee CS, Lee SC, Ahn JG. Epidemiology of pediatric uveitis and associated systemic diseases. Pediatr Rheumatol Online J 2021;19(1):48.

Nsiangani Lusambo N, Kaimbo Wa Kaimbo D, Ngoyi Mumba DM, de-la-Torre A. Outcomes of trimethoprim/ sulfamethoxazole treatment for ocular toxoplasmosis in Congolese patients. BMC Ophthalmol 2023;23(1):440.

Fabiani S, Caroselli C, Menchini M, Gabbriellini G, Falcone M, Bruschi F. Ocular toxoplasmosis, an overview focusing on clinical aspects. Acta Trop 2022;225:106180.

Gomez CA, Sahoo MK, Kahn GY, Zhong L, Montoya JG, Pinsky BA, et al. Dual-target, real-time PCR for the diagnosis of intraocular Toxoplasma gondii infections. Br J Ophthalmol 2019;103(4):569-72.

Kalogeropoulos D, Sakkas H, Mohammed B, Vartholomatos G, Malamos K, Sreekantam S, et al. Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches. Int Ophthalmol 2022;42(1):295-321.

Standardization of Uveitis Nomenclature (SUN) Working Group. Classification Criteria for Herpes Simplex Virus Anterior Uveitis. Am J Ophthalmol 2021;228:231-36.

Valerio GS, Lin CC. Ocular manifestations of herpes simplex virus. Curr Opin Ophthalmol 2019;30(6):525-31.

Armitano R, Lisa A, Martínez C, Cipolla L, Iachini R, Prieto M. Bartonella henselae: evidencia serológica en pacientes pediátricos con sospecha clínica de enfermedad por arañazo de gato. Rev Argent Microbiol 2018;50(4):365-8.

Hong H, Li T, Ying Y, An Q, Liu H, Liang K. Cat-scratch disease manifesting as uveitis and binocular fundus nodular lesions: a case report. BMC Ophthalmol 2023;23(1):345.

Habot-Wilner Z, Trivizki O, Goldstein M, Kesler A, Shulman S, Horowitz J, et al. Cat-scratch disease: ocular manifestations and treatment outcome. Acta Ophthalmol 2018;96(4):e524-32.

Sharma K, Gupta V, Bansal R, Sharma A, Sharma M, Gupta A. Novel multi-targeted polymerase chain reaction for diagnosis of presumed tubercular uveitis. J Ophthalmic Inflamm Infect 2013;3(1):25.

Agarwal A, Agrawal R, Gunasekaran DV, Raje D, Gupta B, Aggarwal K, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1 Report 3: Polymerase Chain Reaction in the Diagnosis and Management of Tubercular Uveitis: Global Trends. Ocul Immunol Inflamm 2019;27(3):465-73.

Testi I, Agrawal R, Mehta S, Basu S, Nguyen Q, Pavesio C, et al. Ocular tuberculosis: Where are we today? Indian J Ophthalmol 2020;68(9):1808-17.

Clarke SL, Sen ES, Ramanan AV. Juvenile idiopathic arthritis-associated uveitis. Pediatr Rheumatol Online J 2016;14(1):27.

Angeles-Han ST, Ringold S, Beukelman T, Lovell D, Cuello CA, Becker ML, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis. Arthritis Care Res (Hoboken) 2019;71(6):703-16.

Lazăr C, Spîrchez M, Ştefan M, Predeţeanu D, Nicoară S, Crişan M, et al. Diagnosis and treatment of uveitis associated with juvenile idiopathic arthritis. Med Pharm Rep 2021;94(Suppl No 1):S28-32.

Constantin T, Foeldvari I, Anton J, de Boer J, Czitrom-Guillaume S, Edelsten C, et al. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative. Ann Rheum Dis 2018;77(8):1107-17.

Zina S, Khairallah M, Ben Amor H, Ksiaa I, Hadhri R, Attia S, et al. Granulomes conjonctivaux révélant une sarcoïdose systémique. J Fr Ophtalmol 2022;45(2):e67-9.

Standardization of Uveitis Nomenclature (SUN) Working Group. Classification Criteria for Sarcoidosis-Associated Uveitis. Am J Ophthalmol 2021;228:220-30.

Zhang Y, Du SS, Zhao MM, Li QH, Zhou Y, Song JC, et al. Chest high-resolution computed tomography can make higher accurate stages for thoracic sarcoidosis than X-ray. BMC Pulm Med 2022;22(1):146.

Vender RJ, Aldahham H, Gupta R. The role of PET in the management of sarcoidosis. Curr Opin Pulm Med 2022;28(5):485-91.

Groen-Hakan F, Eurelings L, Rothova A, van Laar J. Lymphopaenia as a predictor of sarcoidosis in patients with a first episode of uveitis. Br J Ophthalmol 2019;103(9):1296-300.

Grumet P, Kodjikian L, de Parisot A, Errera MH, Sedira N, Heron E, et al. Contribution of diagnostic tests for the etiological assessment of uveitis, data from the ULISSE study (Uveitis: Clinical and medicoeconomic evaluation of a standardized strategy of the etiological diagnosis). Autoimmun Rev 2018;17(4):331-43.

Niederer RL, Sims JL. Utility of Screening Investigations for Systemic Sarcoidosis in Undifferentiated Uveitis. Am J Ophthalmol 2019;206:149-53.

Cotte P, Pradat P, Kodjikian L, Jamilloux Y, Seve P. Diagnostic value of lymphopaenia and elevated serum ACE in patients with uveitis. Br J Ophthalmol 2021;105(10):1399-404.

Giorgiutti S, Jacquot R, El Jammal T, Bert A, Jamilloux Y, Kodjikian L, et al. Sarcoidosis-Related Uveitis: A Review. J Clin Med 2023;12(9):3194.

Suresh S, Tsui E. Ocular manifestations of Blau syndrome. Curr Opin Ophthalmol 2020;31(6):532-7.

Sarens IL, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Chédeville G, et al. Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series. Am J Ophthalmol 2018;187:158-66.

Testi I, Agrawal R, Mahajan S, Agarwal A, Gunasekeran DV, Raje D, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Descriptive Review of Tubercular Uveitis in Paediatric Population. Ocul Immunol Inflamm 2020;28(Sup 1):58-64.

Matsuda T, Kambe N, Ueki Y, Kanazawa N, Izawa K, Honda Y, et al. Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation. Ann Rheum Dis 2020;79(11):1492-9.

Agarwal A, Karande S. Blau syndrome: An under-reported condition in India? J Postgrad Med 2022;68(2):63-7.

Concilio M, Cennamo G, Giordano M, Fossataro F, D’Andrea L, Ciampa N, et al. Anterior Segment-Optical Coherence Tomography features in Blau syndrome. Photodiagnosis Photodyn Ther 2021;34:102278.

Standardization of Uveitis Nomenclature (SUN) Working Group. Classification Criteria for Tubulointerstitial Nephritis With Uveitis Syndrome. Am J Ophthalmol 2021;228:255-61.

Sanchez-Quiros J, Giralt L, Fonollosa A, Robles I, Carreño E. Diagnostic and Management Strategies of Tubulointerstitial Nephritis and Uveitis Syndrome (TINU): Current Perspectives. Clin Ophthalmol 2023;17:2625-30.

Amaro D, Carreño E, Steeples LR, Oliveira-Ramos F, Marques-Neves C, Leal I. Tubulointerstitial nephritis and uveitis (TINU) syndrome: a review. Br J Ophthalmol 2020;104(6):742-7.

Kawai H, Suzuki Y, Shiojiri T. Usefulness of renal diffusion-weighted magnetic resonance imaging for early diagnosis of tubulointerstitial nephritis and uveitis (TINU) syndrome. BMJ Case Rep 2022;15(2):e246434.

Standardization of Uveitis Nomenclature (SUN) Working Group. Classification Criteria for Behçet Disease Uveitis. Am J Ophthalmol 2021;228:80-8.

Butbul Aviel Y, Batu ED, Sözeri B, Aktay Ayaz N, Baba L, Amarilyo G, et al. Characteristics of pediatric Behçet’s disease in Turkey and Israel: A cross-sectional cohort comparison. Semin Arthritis Rheum 2020;50(3):515-20.

Joubert M, Desbois AC, Domont F, Ghembaza A, Le Joncour A, Mirouse A, et al. Behçet’s Disease Uveitis. J Clin Med 2023;12(11):3648.

Çakar Özdal P. Behçet’s Uveitis: Current Diagnostic and Therapeutic Approach. Turk J Ophthalmol 2020;50(3):169-82.

Abucham-Neto JZ, Torricelli AAM, Lui ACF, Guimarães SN, Nascimento H, Regatieri CV. Comparison between optical coherence tomography angiography and fluorescein angiography findings in retinal vasculitis. Int J Retina Vitreous 2018;4:15.

Accorinti M, Gilardi M, De Geronimo D, Iannetti L, Giannini D, Parravano M. Optical Coherence Tomography Angiography Findings in Active and Inactive Ocular Behçet Disease. Ocul Immunol Inflamm 2020;28(4):589-600.

Standardization of Uveitis Nomenclature (SUN) Working Group. Classification Criteria for Spondyloarthritis/HLA-B27-Associated Anterior Uveitis. Am J Ophthalmol 2021;228:117-25.

Rademacher J, Poddubnyy D, Pleyer U. Uveitis in spondyloarthritis. Ther Adv Musculoskelet Dis 2020;12:1759720X20951733.

Dias-Santos A, Tavares Ferreira J, Pinheiro S, Cunha JP, Alves M, Papoila AL, et al. Neurodegeneration in systemic lupus erythematosus: layer by layer retinal study using optical coherence tomography. Int J Retina Vitreous 2020;6:15.

Luboń W, Luboń M, Kotyla P, Mrukwa-Kominek E. Understanding Ocular Findings and Manifestations of Systemic Lupus Erythematosus: Update Review of the Literature. Int J Mol Sci 2022;23(20):12264.

Özdal PÇ, Tugal-Tutkun I. Choroidal involvement in systemic vasculitis: a systematic review. J Ophthalmic Inflamm Infect 2022;12(1):14.

Standardization of Uveitis Nomenclature (SUN) Working Group. Classification Criteria for Multiple Sclerosis-Associated Intermediate Uveitis. Am J Ophthalmol 2021;228:72-9.

Casselman P, Cassiman C, Casteels I, Schauwvlieghe PP. Insights into multiple sclerosis-associated uveitis: a scoping review. Acta Ophthalmol 2021;99(6):592-603.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17(2):162-73.

Standardization of Uveitis Nomenclature (SUN) Working Group. Classification Criteria for Vogt-Koyanagi-Harada Disease. Am J Ophthalmol 2021;228:205-11.

Xu K, Gao B, Li J, Xiang Y, Cao L, Zhao M. Clinical features, diagnosis, and management of COVID-19 vaccine-associated Vogt-Koyanagi-Harada disease. Hum Vaccin Immunother 2023;19(2):2220630.

Cruzado-Sánchez D, Tellez WA, Barriga-Salaverry G, Luglio-Valdivieso H, Luján-Najar S. Wide-field angiography for diagnosis and follow-up of Eales disease: a case series. Arq Bras Oftalmol 2019;82(4):339-44.

Hsia NY, Li YL, Lin CJ, Bair H, Lai CT, Lin JM, et al. Ultra-widefield angiography in the diagnosis and management of uveitis. Taiwan J Ophthalmol 2018;8(3):159-63.

Callejas Rubio JL, García Serrano JL, Ortego Centeno N. Retinal vasculitis and Eales disease. Enfermedad de Eales: otra causa de vasculitis retiniana. Med Clin (Barc) 2018;151(8):336.

Kharel Sitaula R, Iyer V, Noronha V, Dutta Majumder P, Biswas J. Role of high-resolution computerized tomography chest in identifying tubercular etiology in patients diagnosed as Eales’ disease. J Ophthalmic Inflamm Infect 2017;7(1):4.


Copyright (c) 2024 Monika Modrzejewska, Oliwia Zdanowska, Dawid Świstara

License URL: